Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://aoifeftiw249851.atualblog.com/45553708/retaglutide-a-promising-glp-1-receptor-agonist